Estabrook Capital Management Merck & Co., Inc. Transaction History

Estabrook Capital Management

$671 Billion
Q3 2024

A detailed history of Estabrook Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Estabrook Capital Management holds 98,332 shares of MRK stock, worth $9.64 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

98,332

Previous 98,724 0.4%

Holding current value

$9.64 Million

Previous $12.2 Billion 8.64%

% of portfolio

1.66%

Previous 1.88%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $43,570 - $50,556	-392 Reduced 0.4%	98,332 $11.2 Billion
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $264,932 - $284,534	-2,140 Reduced 2.12%	98,724 $12.2 Billion
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $255,809 - $298,075	-2,259 Reduced 2.19%	100,864 $13.3 Billion
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $51,993 - $56,581	-519 Reduced 0.5%	103,123 $11.2 Billion
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $157,822 - $175,267	-1,533 Reduced 1.46%	103,642 $10.7 Billion
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $83,195 - $90,679	-766 Reduced 0.72%	105,175 $12.1 Billion
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $112,204 - $125,197	-1,090 Reduced 1.02%	105,941 $11.3 Billion
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $186,946 - $239,691	-2,138 Reduced 1.96%	107,031 $11.9 Billion
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $29,162 - $32,761	-345 Reduced 0.32%	109,169 $9.4 Billion
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $253,141 - $286,948	-3,032 Reduced 2.69%	109,514 $9.98 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $135,772 - $152,192	1,847 Added 1.67%	112,546 $9.23 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $90,783 - $113,718	-1,256 Reduced 1.12%	110,699 $8.48 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $154,542 - $169,957	-2,156 Reduced 1.89%	111,955 $8.41 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $73,895 - $81,736	1,051 Added 0.93%	114,111 $8.87 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $101,912 - $120,042	-1,480 Reduced 1.29%	113,060 $8.32 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $221,769 - $246,118	-3,090 Reduced 2.63%	114,540 $8.94 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $255,764 - $289,910	-3,495 Reduced 2.89%	117,630 $9.31 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $263,652 - $300,006	-3,744 Reduced 3.0%	121,125 $8.94 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $307,486 - $426,190	-4,853 Reduced 3.74%	124,869 $9.17 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $133,437 - $150,568	-1,720 Reduced 1.31%	129,722 $11.3 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $410,071 - $446,992	-5,390 Reduced 3.94%	131,442 $10.6 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $305,270 - $356,629	-4,371 Reduced 3.1%	136,832 $0
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $53,298 - $60,789	766 Added 0.55%	141,203 $0
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $210,464 - $244,240	-3,226 Reduced 2.25%	140,437 $10.2 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $205,434 - $241,578	-3,561 Reduced 2.42%	143,663 $0
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $254,556 - $299,077	-5,008 Reduced 3.29%	147,224 $0
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $103,805 - $120,651	-2,037 Reduced 1.32%	152,232 $0
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $248,498 - $296,734	4,814 Added 3.22%	154,269 $0
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $8.77 Million - $9.44 Million	149,455	149,455 $0

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Estabrook Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Estabrook Capital Management with notifications on news.

Account

Estabrook Capital Management Merck & Co., Inc. Transaction History